Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial results ...

While Freeport has performed well over the last decade, the company has significantly underperformed the S&P 500 ( SPY) over ...

MarketAxess is rebounding with accelerating growth, rising profitability, and a strong industry backdrop, despite a 70% drop ...

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be ...